Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.

Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.

In the cellular immune response, recognition by CTL-TCRs of viral antigens presented as peptides by HLA class I molecules, triggers destruction of the virally infected cell (Townsend, A.R.M., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. Cell. 44:959-968). Altered peptide...

Full description

Bibliographic Details
Main Authors:	Reid, S, McAdam, S, Smith, K, Klenerman, P, O'Callaghan, C, Harlos, K, Jakobsen, B, McMichael, A, Bell, J, Stuart, D, Jones, E
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Production and crystallization of MHC class I B allele single peptide complexes.
by: Reid, S, et al.
Published: (1996)

Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.
by: Smith, K, et al.
Published: (1996)

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
by: O'Callaghan, C, et al.
Published: (1998)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
by: Mcadam, S, et al.
Published: (1995)

Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
by: Vessey, S, et al.
Published: (1997)

Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80).
by: Klenerman, P, et al.
Published: (1996)

Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes.
by: Goulder, P, et al.
Published: (1997)

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
by: Dong, T, et al.
Published: (1996)

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
by: McAdam, S, et al.
Published: (1995)

Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.
by: O'Callaghan, C, et al.
Published: (1998)

Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E.
by: O'Callaghan, C, et al.
Published: (1998)

Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
by: Allan, D, et al.
Published: (2002)

Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
by: Gao, G, et al.
Published: (1997)

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
by: Dorrell, L, et al.
Published: (2001)

An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
by: Smith, K, et al.
Published: (1996)

Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2.
by: Gao, G, et al.
Published: (1998)

Crystal structure of the complex between CD8αα human and HLA-A2
by: Gao, G, et al.
Published: (1997)

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
by: Klenerman, P, et al.
Published: (1994)

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes
by: Walters, LC, et al.
Published: (2022)

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
by: Li, D, et al.
Published: (2022)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
by: Walters, L, et al.
Published: (2018)

HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities
by: Yang, H, et al.
Published: (2021)

HIV/AIDS. HLA leaves its footprints on HIV.
by: McMichael, A, et al.
Published: (2002)

HLA-peptide tetrameric complexes.
by: Ogg, G, et al.
Published: (1998)

Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.
by: Walters, LC, et al.
Published: (2018)

The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.
by: Hourigan, C, et al.
Published: (2006)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
by: Barouch, D, et al.
Published: (1995)

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes
by: Lucy C. Walters, et al.
Published: (2022-06-01)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
by: Bodmer, H, et al.
Published: (1989)

Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705.
by: Rowland-Jones, S, et al.
Published: (1998)

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay
by: Walters, LC, et al.
Published: (2020)

Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.
by: Lepin, E, et al.
Published: (2000)

Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
by: Allen, R, et al.
Published: (1999)

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
by: Kelleher, A, et al.
Published: (2001)

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
by: Kelleher, A, et al.
Published: (2001)

HIV-gag-specific cytotoxic T lymphocytes.
by: Nixon, D, et al.
Published: (1989)

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.
by: Honeyborne, I, et al.
Published: (2007)

Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.
by: Moss, P, et al.
Published: (1991)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
by: Tussey, L, et al.
Published: (1994)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
by: Lucy C. Walters, et al.
Published: (2018-08-01)